Joined August 2011
- Tweets 54
- Following 147
- Followers 131
- Likes 37
1 Photos and videos
8 Jul 2025
When political agendas try to reshape science, integrity is the first casualty.
Assigning the power to “correct” scientific information to political appointees is not the way forward.
doi.org/10.1192/bjp.2025.103…
#ScienceIntegrity #ScientificFreedom #ResearchEthics #OpenScience
46
24 Apr 2025
Please read this important Editorial from BJPsych, written by 22 Journal Editors of Scientific Psychiatic Journals.
doi.org/10.1192/bjp.2025.94
@scnpjournal
#MentalHealthResearch
#ScienceIntegrity
#AcademicFreedom
#MentalHealthPolicy
#ScientificTruth
1
4
71
Gregers Wegener retweeted
9 Apr 2025
Another one on GLP-1 receptor agonists (GLP-1RA)— Could they be a new avenue for alcohol use disorder (AUD) treatment? 🍷🚫
This recent review explored the GLP-1RAs potential (as liraglutide/semaglutide) in modulating alcohol-related behaviors in preclinical and clinical studies
1
2
4
270
Gregers Wegener retweeted
21 Jan 2025
Looking for a home to your paper on #Psychopharmacology or #Immunopsychiatry?
Look no further!
Final submissions are due February 1st on the Journal submission site. Check the guide for authors on:
cambridge.org/core/journals/…
2
4
188
Gregers Wegener retweeted
2 Jan 2025
🌟Neuropsychiatric disorders 🧠 are frequently associated with metabolic comorbidities. The contributions of our most recent Special Issue present a diverse array of studies that illustrate the breadth of Metabolic Neuropsychiatry.
Check it out 🧵: cambridge.org/core/journals/…
2
4
11
353
Gregers Wegener retweeted
18 Dec 2024
This new study from Dr. Harkin’s group aimed to investigate mRNA expression of the kynurenine pathway (KP) enzymes in medicated patients with depression and healthy controls, and in patients with depression after electroconvulsive therapy (ECT). 🧬🧠
doi.org/10.1017/neu.2024.34
1
1
2
89
Gregers Wegener retweeted
29 Oct 2024
We are pleased to introduce the 1st special issue of Acta Neuropsychiatrica, which is dedicated to exploring the role of #cannabinoids in #psychiatric research and treatment.
cambridge.org/.../5689042CA8…...
2
1
5
121
Gregers Wegener retweeted
24 Oct 2024
Just out now!!
In this double-blind randomized withdrawal trial, McIntyre et al didn't observed differences of adjunctive brexpiprazole in time to relapse, but the association was superior to placebo at other endpoints (check the paper to discover which ones).
1
1
1
80
Gregers Wegener retweeted
23 Sep 2024
Today, September 23th, Editor-in-chief will be at the ECNP plaza to share more about the journal and to advise you on the publishing process and discuss the scope of Acta Neuropsychiatrica.
#neuropsychopharmacology
#Neuroscience
#Research
#ecnp
2
3
129
Gregers Wegener retweeted
4 Jul 2024
Feel free to check out our new paper written by my colleague Anna Gannedahl showing an impact of socioeconomic status on depression care in a sample of over 100 000 patients.
pubmed.ncbi.nlm.nih.gov/3891…
3
5
276
Gregers Wegener retweeted
4 Jul 2024
We will go fully OA in 2025 but we will keep all efforts to removing publishing barriers.
Acta Neuropsychiatrica welcomes research papers from around the globe and will continue to foster inclusive #openscience.
Access the website for more info: cambridge.org/core/journals/…
2
8
160
Gregers Wegener retweeted
28 Jun 2024
New journal @scnpjournal - Acta Neuropsychiatrica - joins the NPRC!
Read more about us and our participating journals at nprc.incf.org
#neuroscience #neuroinformatics
2
4
76
Gregers Wegener retweeted
13 Jun 2024
⭐️ Big News: Acta Neuropsychiatrica’s CiteScore Soars to 8.5! 🏆 Ranked 10th in #Neuroscience (51 journals) & 66th in #Psychiatry (567 journals). 📊 Our CiteScore reflects the high-impact work of our authors & community trust.
1
3
7
161
Gregers Wegener retweeted
7 Jun 2024
After this week's debates on #PTSD and in recognition of #DDay, we share this recent paper by @RachelYehuda group. The study found harassment during deployment correlated w/ higher suicidal ideation and lower testosterone levels. Read more: cambridge.org/core/journals/… #MentalHealth
1
5
129
Gregers Wegener retweeted
5 Jun 2024
In light of the FDA discussion on MDMA therapy for PTSD, did you know the psychostimulant response is mediated by the endocannabinoid system?
Check this paper of @PedroGobira et al. on Acta Neuropsychiatrica
cambridge.org/core/journals/…
#MDMA #psychostimulant #FDA #MentalHealth
3
10
145
Gregers Wegener retweeted
4 Jun 2024
📢 Exciting News: Acta Neuropsychiatrica joins the Neuroscience Peer Review Consortium (NPRC)!
cambridge.org/core/journals/…
#NPRC
#NeuroscienceCollaboration
#PeerReview
#NeuroscienceResearch
#ScientificPublishing
#MEDLINEJournals
#ResearchExcellence
#Academicchatter
1
2
5
128
Gregers Wegener retweeted
30 May 2024
SCNP 62nd Annual Congress live!
Winner of the 'Young Scientists Symposium' announced.
We are pleased to award the 2024 prize to Eleonora Genovese for her talk.
@scnporg
@goteborgsuni
@tnu_au_dk
#SCNP2024 #SCNP #research
5
9
252
Gregers Wegener retweeted
20 May 2024
🧠 OUT IN ACTA! Toffanin et al. investigated the effects of ECT on brain cortical thickness in major depression.
🔍 Discover the regions that exhibit the most pronounced increases in cortical thickness
cambridge.org/core/journals/…
1
3
103
Gregers Wegener retweeted
29 Oct 2023
On #StrokeAwarenessDay, let's explore the changes in affective temperaments on stroke survivors.
🔍 Researchers aimed to uncover the dominant affective temperament after stroke and explore their connection to the disability level.
1
2
2
123
Gregers Wegener retweeted
3 Aug 2023
📣 Calling all Early Career Scientists in Europe! The ECNP Workshop is your chance to meet the research leaders and discuss advances in #BrainDisorders and treatments!
📍 Nice, France
📅14-17 March 2024
Apply by 26 October 👉ecnp.eu/workshop
#neuroscience #ECNP #training
6
12
2,154